Dow Up 0.59% Nasdaq Up 0.75%

Alexion Pharmaceuticals, Inc. (ALXN)

-NasdaqGS
163.41 Up 2.99(1.86%) 4:15PM EDT
|After Hours : 163.43 Up 0.02 (0.01%) 4:50PM EDT
Prev Close:160.42
Open:160.03
Bid:162.20 x 300
Ask:165.20 x 1000
1y Target Est:198.65
Beta:0.62
Earnings Date:Oct 22 - Oct 27 (Est.)
Day's Range:159.11 - 164.06
52wk Range:100.89 - 185.43
Volume:928,828
Avg Vol (3m):1,987,990
Market Cap:32.32B
P/E (ttm):98.80
EPS (ttm):1.65
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ALXN

Comparison

Symbol% ChgMkt Cap
ALXNUp 1.86%32.32B
AMGNUp 0.99%105.84B
BAXUp 0.59%40.62B

Key Statistics

Forward P/E (1 yr):28.42
P/S (ttm):16.52
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :5.01
Quarterly EPS Est (Sep-14) :1.15
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):1.04

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. It offers Soliris (eculizumab), a therapeutic product to treat paroxysmal nocturnal hemoglobinuria (PNH), a genetic blo... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback